-
1
-
-
0037380967
-
Prevention of early-onset group B streptococcal disease in newborns
-
American College of Obstetricians and Gynecologists. 2003. Prevention of early-onset group B streptococcal disease in newborns. Int. J. Gynaecol. Obstet. 81:115-122.
-
(2003)
Int. J. Gynaecol. Obstet.
, vol.81
, pp. 115-122
-
-
-
2
-
-
0034721406
-
Early-onset group B streptococcal disease - United States, 1998-1999
-
Centers for Disease Control and Prevention. 2000. Early-onset group B streptococcal disease - United States, 1998-1999. JAMA 284:1508-1510.
-
(2000)
JAMA
, vol.284
, pp. 1508-1510
-
-
-
3
-
-
0035191957
-
Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada
-
de Azavedo, J. C., M. McGavin, C. Duncan, D. E. Low, and A. McGeer. 2001. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob. Agents Chemother. 45:3504-3508.
-
(2001)
Antimicrob. Agents Chemother.
, vol.45
, pp. 3504-3508
-
-
De Azavedo, J.C.1
McGavin, M.2
Duncan, C.3
Low, D.E.4
McGeer, A.5
-
4
-
-
0034775099
-
High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan
-
Hsueh, P. R., L. J. Teng, L. N. Lee, S. W. Ho, P. C. Yang, and K. T. Luh. 2001. High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Antimicrob. Agents Chemother. 45:3205-3208.
-
(2001)
Antimicrob. Agents Chemother.
, vol.45
, pp. 3205-3208
-
-
Hsueh, P.R.1
Teng, L.J.2
Lee, L.N.3
Ho, S.W.4
Yang, P.C.5
Luh, K.T.6
-
5
-
-
0032838269
-
A variety of gram-positive bacteria carry mobile mef genes
-
Luna, V. A., P. Coates, E. A. Eady, J. H. Cove, T. T. Nguyen, and M. C. Roberts. 1999. A variety of gram-positive bacteria carry mobile mef genes. J. Antimicrob. Chemother. 44:19-25.
-
(1999)
J. Antimicrob. Chemother.
, vol.44
, pp. 19-25
-
-
Luna, V.A.1
Coates, P.2
Eady, E.A.3
Cove, J.H.4
Nguyen, T.T.5
Roberts, M.C.6
-
6
-
-
0035190551
-
Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-Year perspective
-
Murdoch, D. R., and L. B. Reller. 2001. Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective. Antimicrob. Agents Chemother. 45:3623-3624.
-
(2001)
Antimicrob. Agents Chemother.
, vol.45
, pp. 3623-3624
-
-
Murdoch, D.R.1
Reller, L.B.2
-
7
-
-
0038028188
-
-
Document M100-S13 (M2). National Committee for Clinical Laboratory Standards, Wayne, Pa
-
National Committee for Clinical Laboratory Standards. 2003. Performance standards for antimicrobial susceptibility testing. Document M100-S13 (M2). National Committee for Clinical Laboratory Standards, Wayne, Pa.
-
(2003)
Performance Standards for Antimicrobial Susceptibility Testing
-
-
-
8
-
-
0037118991
-
Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC
-
Schrag, S., R. Gorwitz, K. Fultz-Butts, and A. Schuchat. 2002. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. Morb. Mortal. Wkly. Rep. Recomm. Rep. 51:1-22.
-
(2002)
Morb. Mortal. Wkly. Rep. Recomm. Rep.
, vol.51
, pp. 1-22
-
-
Schrag, S.1
Gorwitz, R.2
Fultz-Butts, K.3
Schuchat, A.4
-
9
-
-
0034610804
-
Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis
-
Schrag, S. J., S. Zywicki, M. M. Farley, A. L. Reingold, L. H. Harrison, L. B. Lefkowitz, J. L. Hadler, R. Danila, P. R. Cieslak, and A. Schuchat. 2000. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N. Engl. J. Med. 342:15-20.
-
(2000)
N. Engl. J. Med.
, vol.342
, pp. 15-20
-
-
Schrag, S.J.1
Zywicki, S.2
Farley, M.M.3
Reingold, A.L.4
Harrison, L.H.5
Lefkowitz, L.B.6
Hadler, J.L.7
Danila, R.8
Cieslak, P.R.9
Schuchat, A.10
-
10
-
-
0008721025
-
Statement on the prevention of early-onset group B streptococcal infections in the newborn
-
Society of Obstetricians and Gynaecologists of Canada and Canadian Paediatrics Society. 1997. Statement on the prevention of early-onset group B streptococcal infections in the newborn. J. Obstet. Gynaecol. Can. 19:751-758.
-
(1997)
J. Obstet. Gynaecol. Can.
, vol.19
, pp. 751-758
-
-
-
11
-
-
0141889172
-
Investigation of Staphylococcus aureus isolates identified as erythromycin intermediate by the Vitek-1 system: Comparison with results obtained with the Vitek-2 and Phoenix systems
-
Tang, P., D. E. Low, S. Atkinson, K. Pike, A. Ashi-Sulaiman, A. Simor, S. Richardson, and B. M. Willey. 2003. Investigation of Staphylococcus aureus isolates identified as erythromycin intermediate by the Vitek-1 system: comparison with results obtained with the Vitek-2 and Phoenix systems. J. Clin. Microbiol. 41:4823-4825.
-
(2003)
J. Clin. Microbiol.
, vol.41
, pp. 4823-4825
-
-
Tang, P.1
Low, D.E.2
Atkinson, S.3
Pike, K.4
Ashi-Sulaiman, A.5
Simor, A.6
Richardson, S.7
Willey, B.M.8
-
12
-
-
0035097107
-
Emerging erythromycin resistance among group B streptococci in Korea
-
Uh, Y., I. H. Jang, G. Y. Hwang, K. J. Yoon, and W. Song. 2001. Emerging erythromycin resistance among group B streptococci in Korea. Eur. J. Clin. Microbiol. Infect. Dis. 20:52-54.
-
(2001)
Eur. J. Clin. Microbiol. Infect. Dis.
, vol.20
, pp. 52-54
-
-
Uh, Y.1
Jang, I.H.2
Hwang, G.Y.3
Yoon, K.J.4
Song, W.5
-
13
-
-
0022357292
-
Inducible resistance to macrolides, lincosamides and streptogramin type B antibiotics: The resistance phenotype, its biological diversity, and structural elements that regulate expression - A review
-
Weisblum, B. 1985. Inducible resistance to macrolides, lincosamides and streptogramin type B antibiotics: the resistance phenotype, its biological diversity, and structural elements that regulate expression - a review. J. Antimicrob. Chemother. 16(Suppl. A):63-90.
-
(1985)
J. Antimicrob. Chemother.
, vol.16
, Issue.SUPPL. A
, pp. 63-90
-
-
Weisblum, B.1
|